Atlas Trials

Comparative Study of Two Recombinant Human Erythropoietin Products in Chronic Kidney Disease Patients

Clinical trial NCT06352138 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06352138
Sponsor
Megalabs
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Anemia of Chronic Kidney Disease
Start date
2025-07-01
Primary completion
2027-03-01
Enrollment
280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.